Why Is IMMIX BIOPHARMA INC (IMMX) Stock Moving Today?
By the Top Tier Newswire AI Desk · July 20, 2026 at 12:30 PM ET · reviewed against 4 wire stories
IMMIX BIOPHARMA INC (IMMX) is drawing unusual attention today. Our newswire has captured 4 stories on IMMX across 4 sources in the last 36 hours, with AI sentiment reading bearish (avg 37/100).
Why IMMX stock is moving today
IMMX stock is moving lower today, down nearly 10% as of the latest trade at $9.01. The decline follows the arrest of Immix Biopharma’s chief medical officer and the termination of his employment, which has triggered investor concern and legal inquiries. The stock opened with a 4.0% gap down and has since traded in a volatile range between $8.73 and $10.05.
What Happened
Immix Biopharma shares fell sharply after the company filed an 8-K with the SEC disclosing the termination of its chief medical officer. The termination came in the wake of his arrest, which is being investigated for potential securities fraud. The Kehoe Law Firm has issued a notice encouraging investors to contact them regarding possible claims. The firm cited the arrest as a potential catalyst for investor losses. Meanwhile, a Benzinga article highlighted a STAT News piece that identified the former CMO as a fugitive previously wanted by law enforcement. The firm is also the subject of an ongoing analyst report that raises questions about product safety and adoption rates.
What The Data Shows
The stock is trading at $9.01, down from a 52-week high of $12.14. With a market cap of $729.7 million and a beta of 0.09, the stock has shown relatively low volatility historically. However, today’s session is unusually active, with 2.1 million shares traded, 1.6 times the 3-month daily average. The stock opened with a $9.84 price and has since fallen to a session low of $8.73. The intraday decline reflects heightened uncertainty among investors.
What To Watch
The company has not scheduled an earnings report in the near term. Investors should monitor the breadth of coverage and legal developments in the coming days, particularly as the Kehoe Law Firm and other legal entities assess potential claims.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
IMMX · Jul 20 session (5-min) · -14.39% vs prior close · updated 8:51 PM ETAI sentiment, last 36h · averaged over 4 stories · 37/100 bearish
The headlines behind the move
Story flow · 4 stories on the wire, last 36h · hover or tap a dot for the headline
9d agoBusiness InsiderBEARISH 28General
Immix Biopharma Stock Drops Significantly On News of Chief Medical Officer Arrest - IMMX Investors Encouraged to Contact Kehoe Law Firm, P.C. Regarding Potential Securities Fraud Claims
Philadelphia, Pennsylvania--(Newsfile Corp. - July 20, 2026) - Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of
9d agoSeeking AlphaBEARISH 34General
Immix Biopharma drops after chief medical officer terminated
Immix Biopharma shares slide 14% after ending its chief medical officer’s employment. Read more here.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →